Medicine Price Transparency Under Scrutiny At Next World Health Assembly
Executive Summary
At the forthcoming 72nd World Health Assembly, delegates will discuss a resolution calling for greater transparency on medicine prices.
You may also be interested in...
Pricing And R&D Transparency Proposals Face Pushback At WHA
A draft resolution on the transparency of medicine prices and R&D costs is being discussed this week by World Health Organization members, but the pharmaceutical industry says some measures will be damaging for medicines access.
New Filings At The EMA
New medicines under evaluation at the European Medicines Agency.
UK: Commercial Framework Sheds Light On Working With NHS And NICE
The final text brings some changes, including the introduction of an escalation process when companies and NHS England cannot agree.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: